CAN, M. Et Al. 2012. Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience. Annual European Congress of Rheumatology EULAR, 2012 , 670.

CAN, M., ALİBAZ ÖNER, F., ÖNER, S., ATAGÜNDÜZ, M. P., İNANÇ, G. N., & DİRESKENELİ, R. H., (2012). Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience . Annual European Congress of Rheumatology EULAR, 2012 (pp.670).

CAN, MERYEM Et Al. "Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience," Annual European Congress of Rheumatology EULAR, 2012, 2012

CAN, MERYEM Et Al. "Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience." Annual European Congress of Rheumatology EULAR, 2012 , pp.670, 2012

CAN, M. Et Al. (2012) . "Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience." Annual European Congress of Rheumatology EULAR, 2012 , p.670.

@conferencepaper{conferencepaper, author={MERYEM CAN Et Al. }, title={Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience}, congress name={Annual European Congress of Rheumatology EULAR, 2012}, city={}, country={}, year={2012}, pages={670} }